BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Patel A, Cholkar K, Mitra AK. Recent developments in protein and peptide parenteral delivery approaches. Ther Deliv 2014;5:337-65. [PMID: 24592957 DOI: 10.4155/tde.14.5] [Cited by in Crossref: 92] [Cited by in F6Publishing: 96] [Article Influence: 10.2] [Reference Citation Analysis]
Number Citing Articles
1 Nguyen HX, Nguyen CN. Microneedle-Mediated Transdermal Delivery of Biopharmaceuticals. Pharmaceutics 2023;15. [PMID: 36678906 DOI: 10.3390/pharmaceutics15010277] [Reference Citation Analysis]
2 Theyab A, Alsharif KF, Alzahrani KJ, Oyouni AAA, Hawsawi YM, Algahtani M, Alghamdi S, Alshammary AF. New insight into strategies used to develop long-acting G-CSF biologics for neutropenia therapy. Front Oncol 2022;12:1026377. [PMID: 36686781 DOI: 10.3389/fonc.2022.1026377] [Reference Citation Analysis]
3 Dubashynskaya NV, Bokatyi AN, Dobrodumov AV, Kudryavtsev IV, Trulioff AS, Rubinstein AA, Aquino AD, Dubrovskii YA, Knyazeva ES, Demyanova EV, Nashchekina YA, Skorik YA. Succinyl Chitosan-Colistin Conjugates as Promising Drug Delivery Systems. Int J Mol Sci 2022;24. [PMID: 36613610 DOI: 10.3390/ijms24010166] [Reference Citation Analysis]
4 Eltaher HM, Blokpoel Ferreras LA, Jalal AR, Dixon JE. Direct contact-mediated non-viral gene therapy using thermo-sensitive hydrogel-coated dressings. Biomaterials Advances 2022. [DOI: 10.1016/j.bioadv.2022.213177] [Reference Citation Analysis]
5 Li Y, Champion JA. Self-assembling nanocarriers from engineered proteins: Design, functionalization, and application for drug delivery. Adv Drug Deliv Rev 2022;189:114462. [PMID: 35934126 DOI: 10.1016/j.addr.2022.114462] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Wanselius M, Rodler A, Searle SS, Abrahmsén-alami S, Hansson P. Responsive Hyaluronic Acid–Ethylacrylamide Microgels Fabricated Using Microfluidics Technique. Gels 2022;8:588. [DOI: 10.3390/gels8090588] [Reference Citation Analysis]
7 Majura JJ, Cao W, Chen Z, Htwe KK, Li W, Du R, Zhang P, Zheng H, Gao J. The current research status and strategies employed to modify food-derived bioactive peptides. Front Nutr 2022;9. [DOI: 10.3389/fnut.2022.950823] [Reference Citation Analysis]
8 Ibnat N, Zaman R, Uddin MB, Chowdhury E, Lee CY. Improved systemic half-life of glucagon-like peptide-1-loaded carbonate apatite nanoparticles in rats. World J Diabetes 2022; 13(8): 613-621 [DOI: 10.4239/wjd.v13.i8.613] [Reference Citation Analysis]
9 Li M, Falk BT, Lu X, Schroder R, Mccoy M, Xu W, Yin DH, Gindy ME, D'Addio SM, Su Y. Molecular Mechanism of Antimicrobial Excipient-Induced Aggregation in Parenteral Formulations of Peptide Therapeutics. Mol Pharm 2022. [PMID: 35917158 DOI: 10.1021/acs.molpharmaceut.2c00449] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Vambhurkar G, Amulya E, Sikder A, Shah S, Famta P, Khatri DK, Singh SB, Srivastava S. Nanomedicine based Potentially Transformative Strategies for Colon Targeting of Peptides: State-of-the-art. Colloids and Surfaces B: Biointerfaces 2022. [DOI: 10.1016/j.colsurfb.2022.112816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
11 Pal A, Vel R, Rahaman SH, Sengupta S, Bodhak S. Synthesis and characterizations of sugar-glass nanoparticles mediated protein delivery system for tissue engineering application. Nano Futures 2022;6:025008. [DOI: 10.1088/2399-1984/ac7832] [Reference Citation Analysis]
12 Dubashynskaya NV, Bokatyi AN, Gasilova ER, Dobrodumov AV, Dubrovskii YA, Knyazeva ES, Nashchekina YA, Demyanova EV, Skorik YA. Hyaluronan-colistin conjugates: Synthesis, characterization, and prospects for medical applications. Int J Biol Macromol 2022;215:243-52. [PMID: 35724903 DOI: 10.1016/j.ijbiomac.2022.06.080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Zhang Y, Li C, Wu X, Deng F, Huang F, Zhang Y, Liu J, Gui H, Ma R, Shi L. Nanochaperones tailored for insulin delivery to reduce immune clearance and enhance bioavailability of insulin. Chemical Engineering Journal 2022;435:134866. [DOI: 10.1016/j.cej.2022.134866] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Chen Y, An Q, Teng K, Zhang Y, Zhao Y. Latest development and versatile applications of highly integrating drug delivery patch. European Polymer Journal 2022. [DOI: 10.1016/j.eurpolymj.2022.111164] [Reference Citation Analysis]
15 Wanselius M, Searle S, Rodler A, Tenje M, Abrahmsén-alami S, Hansson P. Microfluidics Platform for Studies of Peptide – Polyelectrolyte Interaction. International Journal of Pharmaceutics 2022. [DOI: 10.1016/j.ijpharm.2022.121785] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Haddadzadegan S, Dorkoosh F, Bernkop-Schnürch A. Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers. Adv Drug Deliv Rev 2022;182:114097. [PMID: 34999121 DOI: 10.1016/j.addr.2021.114097] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 25.0] [Reference Citation Analysis]
17 Aldossary AM, Ekweremadu CS, Offe IM, Alfassam HA, Han S, Onyali VC, Ozoude CH, Ayeni EA, Nwagwu CS, Halwani AA, Almozain NH, Tawfik EA. A Guide to Oral Vaccination: Highlighting Electrospraying as a Promising Manufacturing Technique toward a Successful Oral Vaccine Development. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.03.010] [Reference Citation Analysis]
18 Wu J, Sahoo JK, Li Y, Xu Q, Kaplan DL. Challenges in delivering therapeutic peptides and proteins: A silk-based solution. J Control Release 2022;345:176-89. [PMID: 35157939 DOI: 10.1016/j.jconrel.2022.02.011] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Awuchi CG, Akram M, Owuamanam IC, Ogueke CC, Awuchi CG, Twinomhwezi H. Nanotechnological application of peptide- and protein-based therapeutics. Applications of Nanotechnology in Drug Discovery and Delivery 2022. [DOI: 10.1016/b978-0-12-824408-1.00005-3] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Ghorpade R, Kumar MS. Formulation of peptides and peptidomimetics. Peptide and Peptidomimetic Therapeutics 2022. [DOI: 10.1016/b978-0-12-820141-1.00017-0] [Reference Citation Analysis]
21 Vora D, Dandekar AA, Banga AK. Therapeutic Peptide Delivery: Fundamentals, Formulations, and Recent Advances. Peptide Therapeutics 2022. [DOI: 10.1007/978-3-031-04544-8_5] [Reference Citation Analysis]
22 Guo H, Zhao W, Meng F, Yu Z, Zhang M. Biodegradable nano-porous Mn3O4 with sustainable release for improving the stability and bioactivity of peptide RVPSL. LWT 2021;152:112384. [DOI: 10.1016/j.lwt.2021.112384] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
23 Baradaran B, Mohammadi A, Shamekhi S, Majidazar N, Dilmaghani A, Soofiyani SR, McMillan NA, Lotfipour F, Hallaj-Nezhadi S. A novel method for the development of plasmid DNA-loaded nanoliposomes for cancer gene therapy. Drug Deliv Transl Res 2021. [PMID: 34322851 DOI: 10.1007/s13346-021-01034-0] [Reference Citation Analysis]
24 Ilangala AB, Lechanteur A, Fillet M, Piel G. Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems. Eur J Pharm Biopharm 2021;167:140-58. [PMID: 34311093 DOI: 10.1016/j.ejpb.2021.07.010] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
25 Phyo P, Zhao X, Templeton AC, Xu W, Cheung JK, Su Y. Understanding molecular mechanisms of biologics drug delivery and stability from NMR spectroscopy. Adv Drug Deliv Rev 2021;174:1-29. [PMID: 33609600 DOI: 10.1016/j.addr.2021.02.007] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
26 Oliveira GS, Costa RP, Gomes P, Gomes MS, Silva T, Teixeira C. Antimicrobial Peptides as Potential Anti-Tubercular Leads: A Concise Review. Pharmaceuticals (Basel) 2021;14:323. [PMID: 33918182 DOI: 10.3390/ph14040323] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
27 Orafaie A, Bahrami AR, Matin MM. Use of anticancer peptides as an alternative approach for targeted therapy in breast cancer: a review. Nanomedicine (Lond) 2021;16:415-33. [PMID: 33615876 DOI: 10.2217/nnm-2020-0352] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
28 Ramadon D, McCrudden MTC, Courtenay AJ, Donnelly RF. Enhancement strategies for transdermal drug delivery systems: current trends and applications. Drug Deliv Transl Res 2021. [PMID: 33474709 DOI: 10.1007/s13346-021-00909-6] [Cited by in Crossref: 48] [Cited by in F6Publishing: 39] [Article Influence: 24.0] [Reference Citation Analysis]
29 Kim GC, Cheon DH, Lee Y. Challenge to overcome current limitations of cell-penetrating peptides. Biochim Biophys Acta Proteins Proteom 2021;1869:140604. [PMID: 33453413 DOI: 10.1016/j.bbapap.2021.140604] [Cited by in Crossref: 26] [Cited by in F6Publishing: 32] [Article Influence: 13.0] [Reference Citation Analysis]
30 Essa ML, El-Kemary MA, Ebrahem Saied EM, Leporatti S, Nemany Hanafy NA. Nano targeted Therapies Made of Lipids and Polymers have Promising Strategy for the Treatment of Lung Cancer. Materials (Basel) 2020;13:E5397. [PMID: 33261031 DOI: 10.3390/ma13235397] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
31 Moreira A, Lawson D, Onyekuru L, Dziemidowicz K, Angkawinitwong U, Costa PF, Radacsi N, Williams GR. Protein encapsulation by electrospinning and electrospraying. J Control Release 2021;329:1172-97. [PMID: 33127450 DOI: 10.1016/j.jconrel.2020.10.046] [Cited by in Crossref: 24] [Cited by in F6Publishing: 26] [Article Influence: 8.0] [Reference Citation Analysis]
32 Ibeanu N, Egbu R, Onyekuru L, Javaheri H, Khaw PT, Williams GR, Brocchini S, Awwad S. Injectables and Depots to Prolong Drug Action of Proteins and Peptides. Pharmaceutics 2020;12:E999. [PMID: 33096803 DOI: 10.3390/pharmaceutics12100999] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 6.0] [Reference Citation Analysis]
33 Jana S, Gandhi A, Roy C. Marine Biomaterials‐Based Systems. In: Kim S, editor. Encyclopedia of Marine Biotechnology. Wiley; 2020. pp. 1141-74. [DOI: 10.1002/9781119143802.ch47] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
34 Czech T, Oyewumi MO. Overcoming barriers confronting application of protein therapeutics in bone fracture healing. Drug Deliv Transl Res 2021;11:842-65. [PMID: 32783153 DOI: 10.1007/s13346-020-00829-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
35 Zhang Y, Zhang H, Ghosh D, Williams RO 3rd. Just how prevalent are peptide therapeutic products? A critical review. Int J Pharm 2020;587:119491. [PMID: 32622810 DOI: 10.1016/j.ijpharm.2020.119491] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 5.7] [Reference Citation Analysis]
36 Guillot AJ, Cordeiro AS, Donnelly RF, Montesinos MC, Garrigues TM, Melero A. Microneedle-Based Delivery: An Overview of Current Applications and Trends. Pharmaceutics 2020;12:E569. [PMID: 32575392 DOI: 10.3390/pharmaceutics12060569] [Cited by in Crossref: 55] [Cited by in F6Publishing: 59] [Article Influence: 18.3] [Reference Citation Analysis]
37 Priwitaningrum DL, Jentsch J, Bansal R, Rahimian S, Storm G, Hennink WE, Prakash J. Apoptosis-inducing peptide loaded in PLGA nanoparticles induces anti-tumor effects in vivo. Int J Pharm 2020;585:119535. [PMID: 32534162 DOI: 10.1016/j.ijpharm.2020.119535] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
38 Shetab Boushehri MA, Dietrich D, Lamprecht A. Nanotechnology as a Platform for the Development of Injectable Parenteral Formulations: A Comprehensive Review of the Know-Hows and State of the Art. Pharmaceutics 2020;12:E510. [PMID: 32503171 DOI: 10.3390/pharmaceutics12060510] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 5.7] [Reference Citation Analysis]
39 Arif M, Ahmad S, Ali F, Fang G, Li M, Yu DJ. TargetCPP: accurate prediction of cell-penetrating peptides from optimized multi-scale features using gradient boost decision tree. J Comput Aided Mol Des 2020;34:841-56. [PMID: 32180124 DOI: 10.1007/s10822-020-00307-z] [Cited by in Crossref: 22] [Cited by in F6Publishing: 13] [Article Influence: 7.3] [Reference Citation Analysis]
40 Jamaledin R, Di Natale C, Onesto V, Taraghdari ZB, Zare EN, Makvandi P, Vecchione R, Netti PA. Progress in Microneedle-Mediated Protein Delivery. J Clin Med 2020;9:E542. [PMID: 32079212 DOI: 10.3390/jcm9020542] [Cited by in Crossref: 57] [Cited by in F6Publishing: 59] [Article Influence: 19.0] [Reference Citation Analysis]
41 Rajapaksha RDAA. Self-assembling smart materials for biomaterials applications. Polymer Nanocomposite-Based Smart Materials 2020. [DOI: 10.1016/b978-0-08-103013-4.00007-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
42 Raffa V. Engineering magnetic nanoparticles for repairing nerve injuries. Advances in Nanostructured Materials and Nanopatterning Technologies. Elsevier; 2020. pp. 167-200. [DOI: 10.1016/b978-0-12-816865-3.00007-x] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
43 Salatin S, Barar J, Barzegar-Jalali M, Adibkia K, Alami-Milani M, Jelvehgari M. Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine. Adv Pharm Bull 2020;10:20-9. [PMID: 32002358 DOI: 10.15171/apb.2020.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 4.5] [Reference Citation Analysis]
44 Polley P, Gupta S, Singh R, Pradhan A, Basu SM, V. R, Yadava SK, Giri J. Protein–Sugar-Glass Nanoparticle Platform for the Development of Sustained-Release Protein Depots by Overcoming Protein Delivery Challenges. Mol Pharmaceutics 2020;17:284-300. [DOI: 10.1021/acs.molpharmaceut.9b01022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
45 Wu C, Mu H. Lipid and PLGA Microparticles for Sustained Delivery of Protein and Peptide Drugs. Pharm Nanotechnol 2020;8:22-32. [PMID: 31663483 DOI: 10.2174/2211738507666191029160944] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
46 Soares AMDS, Wanderley LF, Costa Junior LM. The potential of plant and fungal proteins in the control of gastrointestinal nematodes from animals. Rev Bras Parasitol Vet 2019;28:339-45. [PMID: 31291435 DOI: 10.1590/S1984-29612019046] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
47 Alavi SE, Cabot PJ, Moyle PM. Glucagon-Like Peptide-1 Receptor Agonists and Strategies To Improve Their Efficiency. Mol Pharm 2019;16:2278-95. [PMID: 31050435 DOI: 10.1021/acs.molpharmaceut.9b00308] [Cited by in Crossref: 31] [Cited by in F6Publishing: 35] [Article Influence: 7.8] [Reference Citation Analysis]
48 Datta-Mannan A. Mechanisms Influencing the Pharmacokinetics and Disposition of Monoclonal Antibodies and Peptides. Drug Metab Dispos 2019;47:1100-10. [PMID: 31043438 DOI: 10.1124/dmd.119.086488] [Cited by in Crossref: 47] [Cited by in F6Publishing: 49] [Article Influence: 11.8] [Reference Citation Analysis]
49 Tabet A, Wang C. Gels without Vapor Pressure: Soft, Nonaqueous, and Solvent-Free Supramolecular Biomaterials for Prospective Parenteral Drug Delivery Applications. Adv Healthc Mater 2019;8:e1800908. [PMID: 30450824 DOI: 10.1002/adhm.201800908] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
50 Batista P, Castro P, Madureira AR, Sarmento B, Pintado M. Development and Characterization of Chitosan Microparticles-in-Films for Buccal Delivery of Bioactive Peptides. Pharmaceuticals (Basel) 2019;12:E32. [PMID: 30791572 DOI: 10.3390/ph12010032] [Cited by in Crossref: 34] [Cited by in F6Publishing: 36] [Article Influence: 8.5] [Reference Citation Analysis]
51 Bolhassani A. Improvements in chemical carriers of proteins and peptides. Cell Biol Int 2019;43:437-52. [PMID: 30672055 DOI: 10.1002/cbin.11108] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 3.3] [Reference Citation Analysis]
52 Ghazali FC, Edinur HA, Sirajudeen KNS, Aroyehun AQB, Razak SA. The value of geochemical signatures marine by-products, with highlights from taxonomies sea cucumbers, macroalgae and crown of thorns starfish. 6TH INTERNATIONAL CONFERENCE ON ENVIRONMENT (ICENV2018): Empowering Environment and Sustainable Engineering Nexus Through Green Technology 2019. [DOI: 10.1063/1.5117081] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
53 Pudlarz A, Szemraj J. Nanoparticles as Carriers of Proteins, Peptides and Other Therapeutic Molecules. Open Life Sci 2018;13:285-98. [PMID: 33817095 DOI: 10.1515/biol-2018-0035] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
54 Basu S, Pacelli S, Feng Y, Lu Q, Wang J, Paul A. Harnessing the Noncovalent Interactions of DNA Backbone with 2D Silicate Nanodisks To Fabricate Injectable Therapeutic Hydrogels. ACS Nano 2018;12:9866-80. [PMID: 30189128 DOI: 10.1021/acsnano.8b02434] [Cited by in Crossref: 70] [Cited by in F6Publishing: 72] [Article Influence: 14.0] [Reference Citation Analysis]
55 Shimizu T, Abu Lila AS, Awata M, Kubo Y, Mima Y, Hashimoto Y, Ando H, Okuhira K, Ishima Y, Ishida T. A Cell Assay for Detecting Anti-PEG Immune Response against PEG-Modified Therapeutics. Pharm Res 2018;35. [DOI: 10.1007/s11095-018-2505-3] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
56 Khan J, Alexander A, Ajazuddin, Saraf S, Saraf S. Exploring the role of polymeric conjugates toward anti-cancer drug delivery: Current trends and future projections. International Journal of Pharmaceutics 2018;548:500-14. [DOI: 10.1016/j.ijpharm.2018.06.060] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
57 Nnyigide OS, Hyun K. Rheo-kinetics of bovine serum albumin in catanionic surfactant systems. Korean J Chem Eng 2018;35:1969-78. [DOI: 10.1007/s11814-018-0128-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
58 Nnyigide OS, Hyun K. Effects of anionic and cationic surfactants on the rheological properties and kinetics of bovine serum albumin hydrogel. Rheol Acta 2018;57:563-73. [DOI: 10.1007/s00397-018-1100-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
59 Auwal SM, Zarei M, Tan CP, Basri M, Saari N. Enhanced physicochemical stability and efficacy of angiotensin I-converting enzyme (ACE) - inhibitory biopeptides by chitosan nanoparticles optimized using Box-Behnken design. Sci Rep 2018;8:10411. [PMID: 29991723 DOI: 10.1038/s41598-018-28659-5] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
60 Liu H, Jiang P, Li Z, Li X, Djaker N, Spadavecchia J. HIV-1 Tat Peptide-Gemcitabine Gold (III)-PEGylated Complex-Nanoflowers: A Sleek Thermosensitive Hybrid Nanocarrier as Prospective Anticancer. Part Part Syst Charact 2018;35:1800082. [DOI: 10.1002/ppsc.201800082] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
61 Joanitti GA, Sawant RS, Torchilin VP, Freitas SM, Azevedo RB. Optimizing liposomes for delivery of Bowman-Birk protease inhibitors - Platforms for multiple biomedical applications. Colloids Surf B Biointerfaces 2018;167:474-82. [PMID: 29723819 DOI: 10.1016/j.colsurfb.2018.04.033] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
62 Faya M, Kalhapure RS, Kumalo HM, Waddad AY, Omolo C, Govender T. Conjugates and nano-delivery of antimicrobial peptides for enhancing therapeutic activity. Journal of Drug Delivery Science and Technology 2018;44:153-71. [DOI: 10.1016/j.jddst.2017.12.010] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
63 Kaplan M, Tuğcu-demiröz F, Vural İ, Çelebi N. Development and characterization of gels and liposomes containing ovalbumin for nasal delivery. Journal of Drug Delivery Science and Technology 2018;44:108-17. [DOI: 10.1016/j.jddst.2017.12.006] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
64 Romanelli A, Affinito A, Avitabile C, Catuogno S, Ceriotti P, Iaboni M, Modica J, Condorelli G, Catalucci D. An anti-PDGFRβ aptamer for selective delivery of small therapeutic peptide to cardiac cells. PLoS One 2018;13:e0193392. [PMID: 29513717 DOI: 10.1371/journal.pone.0193392] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
65 Stewart TS, Nagesetti A, Guduru R, Liang P, Stimphil E, Hadjikhani A, Salgueiro L, Horstmyer J, Cai R, Schally A, Khizroev S. Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields. Nanomedicine (Lond) 2018;13:423-38. [PMID: 29345190 DOI: 10.2217/nnm-2017-0300] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 5.4] [Reference Citation Analysis]
66 Batista P, Castro PM, Madureira AR, Sarmento B, Pintado M. Recent insights in the use of nanocarriers for the oral delivery of bioactive proteins and peptides. Peptides 2018;101:112-23. [PMID: 29329977 DOI: 10.1016/j.peptides.2018.01.002] [Cited by in Crossref: 55] [Cited by in F6Publishing: 58] [Article Influence: 11.0] [Reference Citation Analysis]
67 de la Torre C, Domínguez-berrocal L, Murguía JR, Marcos MD, Martínez-máñez R, Bravo J, Sancenón F. ϵ -Polylysine-Capped Mesoporous Silica Nanoparticles as Carrier of the C 9 h Peptide to Induce Apoptosis in Cancer Cells. Chem Eur J 2018;24:1890-7. [DOI: 10.1002/chem.201704161] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 5.0] [Reference Citation Analysis]
68 Agyei D, Tan K, Pan S, Udenigwe CC, Danquah MK. Peptides for biopharmaceutical applications. Peptide Applications in Biomedicine, Biotechnology and Bioengineering 2018. [DOI: 10.1016/b978-0-08-100736-5.00009-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
69 Mueller C, Adler M. Switching from an IV to an SC Formulation—Considerations for Formulation Development and Formulation Bridging. Challenges in Protein Product Development 2018. [DOI: 10.1007/978-3-319-90603-4_26] [Reference Citation Analysis]
70 Pippa N, Pispas S, Demetzos C. Recent advances in micellar-like polyelectrolyte/protein complexes. Design and Development of New Nanocarriers 2018. [DOI: 10.1016/b978-0-12-813627-0.00002-8] [Reference Citation Analysis]
71 Santalices I, Gonella A, Torres D, Alonso MJ. Advances on the formulation of proteins using nanotechnologies. Journal of Drug Delivery Science and Technology 2017;42:155-80. [DOI: 10.1016/j.jddst.2017.06.018] [Cited by in Crossref: 21] [Cited by in F6Publishing: 22] [Article Influence: 3.5] [Reference Citation Analysis]
72 Alami-Milani M, Zakeri-Milani P, Valizadeh H, Salehi R, Salatin S, Naderinia A, Jelvehgari M. Novel Pentablock Copolymers as Thermosensitive Self-Assembling Micelles for Ocular Drug Delivery. Adv Pharm Bull 2017;7:11-20. [PMID: 28507933 DOI: 10.15171/apb.2017.003] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 3.5] [Reference Citation Analysis]
73 Srivastava S, Singh D, Patel S, Singh MR. Role of enzymatic free radical scavengers in management of oxidative stress in autoimmune disorders. Int J Biol Macromol 2017;101:502-17. [PMID: 28342757 DOI: 10.1016/j.ijbiomac.2017.03.100] [Cited by in Crossref: 39] [Cited by in F6Publishing: 41] [Article Influence: 6.5] [Reference Citation Analysis]
74 Pechenov S, Bhattacharjee H, Yin D, Mittal S, Subramony JA. Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery. Adv Drug Deliv Rev 2017;112:106-22. [PMID: 28153578 DOI: 10.1016/j.addr.2017.01.006] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.2] [Reference Citation Analysis]
75 Bochicchio S, Sala M, Spensiero A, Scala MC, Gomez-monterrey IM, Lamberti G, Barba AA. On the design of tailored liposomes for KRX29 peptide delivery. New J Chem 2017;41:11280-90. [DOI: 10.1039/c7nj03115g] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
76 Vozza G, Khalid M, Byrne HJ, Ryan S, Frias J. Nutrition—nutrient delivery. Nutrient Delivery 2017. [DOI: 10.1016/b978-0-12-804304-2.00001-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
77 Joseph M, Trinh HM, Mitra AK. Peptide and Protein-Based Therapeutic Agents∗. Emerging Nanotechnologies for Diagnostics, Drug Delivery and Medical Devices 2017. [DOI: 10.1016/b978-0-323-42978-8.00007-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
78 Agrahari V, Agrahari V, Mitra AK. Nanocarrier fabrication and macromolecule drug delivery: challenges and opportunities. Ther Deliv 2016;7:257-78. [PMID: 27010987 DOI: 10.4155/tde-2015-0012] [Cited by in Crossref: 64] [Cited by in F6Publishing: 70] [Article Influence: 9.1] [Reference Citation Analysis]
79 Maher S, Mrsny RJ, Brayden DJ. Intestinal permeation enhancers for oral peptide delivery. Adv Drug Deliv Rev 2016;106:277-319. [PMID: 27320643 DOI: 10.1016/j.addr.2016.06.005] [Cited by in Crossref: 193] [Cited by in F6Publishing: 199] [Article Influence: 27.6] [Reference Citation Analysis]
80 Naoum GE, Tawadros F, Farooqi AA, Qureshi MZ, Tabassum S, Buchsbaum DJ, Arafat W. Role of nanotechnology and gene delivery systems in TRAIL-based therapies. Ecancermedicalscience 2016;10:660. [PMID: 27594905 DOI: 10.3332/ecancer.2016.660] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
81 Lin H, Zheng D, Li Y, Wang N, Chen S, Fu Y, Xu W, Wei C. Incorporation of VSV-G produces fusogenic plasma membrane vesicles capable of efficient transfer of bioactive macromolecules and mitochondria. Biomed Microdevices 2016;18. [DOI: 10.1007/s10544-016-0066-y] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
82 Zhang D, Wang J, Xu D. Cell-penetrating peptides as noninvasive transmembrane vectors for the development of novel multifunctional drug-delivery systems. J Control Release 2016;229:130-9. [PMID: 26993425 DOI: 10.1016/j.jconrel.2016.03.020] [Cited by in Crossref: 157] [Cited by in F6Publishing: 146] [Article Influence: 22.4] [Reference Citation Analysis]
83 Kovalainen M, Mönkäre J, Riikonen J, Pesonen U, Vlasova M, Salonen J, Lehto VP, Järvinen K, Herzig KH. Novel delivery systems for improving the clinical use of peptides. Pharmacol Rev 2015;67:541-61. [PMID: 26023145 DOI: 10.1124/pr.113.008367] [Cited by in Crossref: 54] [Cited by in F6Publishing: 54] [Article Influence: 7.7] [Reference Citation Analysis]
84 Varamini P, Toth I. Recent advances in oral delivery of peptide hormones. Expert Opinion on Drug Delivery 2016;13:507-22. [DOI: 10.1517/17425247.2016.1142526] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 1.7] [Reference Citation Analysis]
85 Jensen SS, Jensen H, Møller EH, Cornett C, Siepmann F, Siepmann J, Østergaard J. In vitro release studies of insulin from lipid implants in solution and in a hydrogel matrix mimicking the subcutis. European Journal of Pharmaceutical Sciences 2016;81:103-12. [DOI: 10.1016/j.ejps.2015.10.011] [Cited by in Crossref: 29] [Cited by in F6Publishing: 29] [Article Influence: 4.1] [Reference Citation Analysis]
86 Zhang J, Desale SS, Bronich TK. Polymer-based vehicles for therapeutic peptide delivery. Ther Deliv 2015;6:1279-96. [PMID: 26599420 DOI: 10.4155/tde.15.71] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
87 Seufert J. New insulin developments. Clinical Advances in Diabetes Mellitus 2015. [DOI: 10.4155/fseb2013.14.419] [Reference Citation Analysis]
88 Niikura K, Horisawa K, Doi N. A fusogenic peptide from a sea urchin fertilization protein promotes intracellular delivery of biomacromolecules by facilitating endosomal escape. Journal of Controlled Release 2015;212:85-93. [DOI: 10.1016/j.jconrel.2015.06.020] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
89 Arima H, Hayashi Y, Higashi T, Motoyama K. Recent advances in cyclodextrin delivery techniques. Expert Opinion on Drug Delivery 2015;12:1425-41. [DOI: 10.1517/17425247.2015.1026893] [Cited by in Crossref: 38] [Cited by in F6Publishing: 39] [Article Influence: 4.8] [Reference Citation Analysis]
90 Matteucci E, Giampietro O, Covolan V, Giustarini D, Fanti P, Rossi R. Insulin administration: present strategies and future directions for a noninvasive (possibly more physiological) delivery. Drug Des Devel Ther 2015;9:3109-18. [PMID: 26124635 DOI: 10.2147/DDDT.S79322] [Cited by in Crossref: 49] [Cited by in F6Publishing: 49] [Article Influence: 6.1] [Reference Citation Analysis]
91 Schall N, Muller S. Resetting the autoreactive immune system with a therapeutic peptide in lupus. Lupus 2015;24:412-8. [DOI: 10.1177/0961203314556138] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
92 Cupri S, Musumeci T, Graziano ACE, Caggia S, Cardile V, Pignatello R. Evaluation of amphiphilic PEG derivatives as surface modifiers for the production of stealth liposomes. Colloid Polym Sci 2015;293:1083-92. [DOI: 10.1007/s00396-014-3465-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
93 Turner CT, Mcinnes SJP, Voelcker NH, Cowin AJ. Therapeutic Potential of Inorganic Nanoparticles for the Delivery of Monoclonal Antibodies. Journal of Nanomaterials 2015;2015:1-11. [DOI: 10.1155/2015/309602] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
94 Guglietta A. The Past, Present, and Future of Drug Development and Treatment in Sleep Disorders. Drug Treatment of Sleep Disorders 2015. [DOI: 10.1007/978-3-319-11514-6_14] [Reference Citation Analysis]
95 Bak A, Leung D, Barrett SE, Forster S, Minnihan EC, Leithead AW, Cunningham J, Toussaint N, Crocker LS. Physicochemical and formulation developability assessment for therapeutic peptide delivery--a primer. AAPS J 2015;17:144-55. [PMID: 25398427 DOI: 10.1208/s12248-014-9688-2] [Cited by in Crossref: 52] [Cited by in F6Publishing: 54] [Article Influence: 5.8] [Reference Citation Analysis]
96 Jin Y, Li Y, Pan H, Dai Z. Liposomal nanohybrid cerasomes for controlled insulin release. RSC Adv 2014;4:42808-15. [DOI: 10.1039/c4ra08515a] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]